Development and validation of an m6A RNA methylation regulator-based signature for the prediction of prognosis and immunotherapy in cutaneous melanoma

Development and validation of an m6A RNA methylation regulator-based signature for the prediction of prognosis and immunotherapy in cutaneous melanoma

Bibliographic Details
Main Authors:	Tingting Li, Xiaoyue Zhang, Caroline Wang, Qiuyu Jia, Lingzhi Zhong, Jian Hu, Houmin Li, Jianzhong Zhang, Lishao Guo
Format:	Article
Language:	English
Published:	Wolters Kluwer 2023-11-01
Series:	Chinese Medical Journal
Online Access:	http://journals.lww.com/10.1097/CM9.0000000000002599

Similar Items

Identification and Validation of Ferroptosis-Related DNA Methylation Signature for Predicting the Prognosis and Guiding the Treatment in Cutaneous Melanoma
by: Wenna Guo, et al.
Published: (2022-12-01)

Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
by: Yujian Xu, et al.
Published: (2022-07-01)

Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning
by: Yi Zhao, et al.
Published: (2023-10-01)

Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma
by: Kefan Lin, et al.
Published: (2023-04-01)

Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma
by: Da Liu, et al.
Published: (2023-01-01)

Retracted: FLG Is a Potential Biomarker of Prognosis and Immunotherapy in Skin Cutaneous Melanoma
by: Applied Bionics and Biomechanics
Published: (2023-01-01)

A novel pyroptosis-associated gene signature for immune status and prognosis of cutaneous melanoma
by: Zhengyuan Wu, et al.
Published: (2021-10-01)

Machine learning-derived identification of tumor-infiltrating immune cell-related signature for improving prognosis and immunotherapy responses in patients with skin cutaneous melanoma
by: Shaolong Leng, et al.
Published: (2023-09-01)

A Novel Necroptosis-Related Gene Signature in Skin Cutaneous Melanoma Prognosis and Tumor Microenvironment
by: Binyu Song, et al.
Published: (2022-07-01)

Gene signature from cutaneous autoimmune diseases provides potential immunotherapy-relevant biomarkers in melanoma
by: Kyu-Hye Chun, et al.
Published: (2023-09-01)

Identification and validation of a ferroptosis‐related gene signature for predicting survival in skin cutaneous melanoma
by: Shuai Ping, et al.
Published: (2022-09-01)

Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer
by: Yichi Zhang, et al.
Published: (2022-01-01)

A combined aging and immune prognostic signature predict prognosis and responsiveness to immunotherapy in melanoma
by: Wenchang Lv, et al.
Published: (2022-08-01)

Construction and validation of a novel prognostic signature for cutaneous melanoma based on ferroptosis-related genes
by: Wenna Guo, et al.
Published: (2023-05-01)

Immune-related gene signature associates with immune landscape and predicts prognosis accurately in patients with skin cutaneous melanoma
by: Xin Shen, et al.
Published: (2023-01-01)

Single-cell sequencing analysis related to sphingolipid metabolism guides immunotherapy and prognosis of skin cutaneous melanoma
by: Yantao Ding, et al.
Published: (2023-11-01)

Cutaneous Events Associated with Immunotherapy of Melanoma: A Review
by: Lorenza Burzi, et al.
Published: (2021-07-01)

Cutaneous Adverse Reactions of Immunotherapy in Patients with Advanced Melanoma
by: Vasiliki Nikolaou, et al.
Published: (2023-03-01)

Establishment and validation of a ferroptosis-related signature predicting prognosis and immunotherapy effect in colon cancer
by: Zhufeng Li, et al.
Published: (2023-05-01)

Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers
by: Pavlina Spiliopoulou, et al.
Published: (2023-01-01)

A Review of Advanced Cutaneous Melanoma Therapies and Their Mechanisms, from Immunotherapies to Lysine Histone Methyl Transferase Inhibitors
by: Renato Santos de Oliveira Filho, et al.
Published: (2023-12-01)

Development and Validation of a Novel Ferroptosis-Related Gene Signature for Prognosis and Immunotherapy in Hepatocellular Carcinoma
by: Bo Zhang, et al.
Published: (2022-06-01)

Development and validation of a ferroptosis-related lncRNAs signature to predict prognosis and microenvironment for melanoma
by: Shuai Ping, et al.
Published: (2022-11-01)

5-Methylcytosine immunohistochemistry for predicting cutaneous melanoma prognosis
by: Jiraroch Meevassana, et al.
Published: (2024-03-01)

Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma
by: Kalle Mattila, et al.
Published: (2023-02-01)

Identification of Pyroptosis-Relevant Signature in Tumor Immune Microenvironment and Prognosis in Skin Cutaneous Melanoma Using Network Analysis
by: Yun Zhu, et al.
Published: (2023-01-01)

Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma
by: Xiaojing Yang, et al.
Published: (2022-09-01)

Biomarkers for Diagnosis, Prognosis and Response to Immunotherapy in Melanoma
by: Rossella Puglisi, et al.
Published: (2021-06-01)

A novel signature for predicting prognosis and immune landscape in cutaneous melanoma based on anoikis-related long non-coding RNAs
by: Miao Zhang, et al.
Published: (2023-09-01)

Proliferation and Immune Response Gene Signatures Associated with Clinical Outcome to Immunotherapy and Targeted Therapy in Metastatic Cutaneous Malignant Melanoma
by: Fernanda Costa Svedman, et al.
Published: (2022-07-01)

Identification of an immune-related signature for the prognosis of uveal melanoma
by: Ying-Zi Li, et al.
Published: (2020-03-01)

Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma
by: Riccardo Marconcini, et al.
Published: (2022-05-01)

Editorial: Mechanisms of resistance to the targeted therapy and immunotherapy in cutaneous melanoma
by: Sanjay Premi, et al.
Published: (2022-08-01)

Cutaneous Melanoma versus Vulvovaginal Melanoma—Risk Factors, Pathogenesis and Comparison of Immunotherapy Efficacy
by: Anna Lorenz, et al.
Published: (2022-10-01)

PTPRC functions as a prognosis biomarker in the tumor microenvironment of cutaneous melanoma
by: Xuemei Li, et al.
Published: (2023-11-01)

Validation of an Ultraviolet Light Response Gene Signature for Predicting Prognosis in Patients with Uveal Melanoma
by: Carlos A. Orozco, et al.
Published: (2023-07-01)

Discovery and Validation of a SIT1-Related Prognostic Signature Associated with Immune Infiltration in Cutaneous Melanoma
by: Ming Jia, et al.
Published: (2022-12-01)

Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma
by: Sen Guo, et al.
Published: (2022-09-01)

An estrogen response-related signature predicts response to immunotherapy in melanoma
by: Min Lin, et al.
Published: (2023-05-01)

PGAM5: A necroptosis gene associated with poor tumor prognosis that promotes cutaneous melanoma progression
by: Jianzhong Peng, et al.
Published: (2022-11-01)